In conclusion, the current study elucidated that circTADA2A could repress fibroblasts activation and proliferation via miR-526b/Cav1 and miR-203/Cav2 pathway, thus alleviating IPF. The gene discussed is CAV2; the disease is idiopathic pulmonary fibrosis.